Alnylam Pharmaceuticals Inc (ALNY) Insider Trading

Total insider buys:
  • $71,277,732.32
Total insider sells:
  • $464,925,039.46
Most recent insider trade:
  • March 3, 2026
Most active insider trader:
  • Akshay Vaishnaw
Trader NameDateTitleAmountPriceTypeTotal Value
March 3, 2026EVP1,775$319.74Sell$567,538.50
March 3, 2026EVP1,652$319.73Sell$528,193.96
March 2, 2026EVP2,206$327.65Sell$722,795.90
March 2, 2026EVP1,717$327.66Sell$562,592.22
March 2, 2026EVP1,598$327.65Sell$523,584.70
March 2, 2026CEO6,799$327.65Sell$2,227,692.35
March 2, 2026EVP1,598$327.65Sell$523,584.70
Feb. 17, 2026EVP2,041$331.96Sell$677,530.36
Feb. 13, 2026EVP2,242$310.08Sell$695,199.36
Feb. 13, 2026CEO6,958$310.08Sell$2,157,536.64
Feb. 13, 2026EVP2,242$310.08Sell$695,199.36
Feb. 13, 2026EVP1,959$310.08Sell$607,446.72
Feb. 13, 2026EVP1,959$310.08Sell$607,446.72
Sept. 9, 2025Director18,000$467.60Sell$8,416,800.00
Aug. 19, 2025EVP1,455$458.41Sell$666,986.55
Aug. 18, 2025CEO6,979$453.27Sell$3,163,371.33
Aug. 18, 2025EVP1,396$453.27Sell$632,764.92
Aug. 18, 2025Director11,250$450.00Sell$5,062,500.00
Aug. 18, 2025EVP2,274$453.27Sell$1,030,735.98
Aug. 18, 2025EVP1,396$453.27Sell$632,764.92
Aug. 18, 2025EVP1,396$453.27Sell$632,764.92
Aug. 14, 2025Director31,448$436.58Sell$13,729,567.84
June 2, 2025CEO19,297$306.00Sell$5,904,882.00
May 30, 2025CEO31,640$304.39Sell$9,630,899.60
Feb. 18, 2025CMO1,548$251.67Sell$389,585.16
Feb. 18, 2025EVP1,440$251.56Sell$362,246.40
Feb. 14, 2025CMO1,561$255.17Sell$398,320.37
Feb. 14, 2025CFO967$255.17Sell$246,749.39
Feb. 14, 2025EVP663$255.21Sell$169,204.23
Feb. 14, 2025CEO1,213$255.17Sell$309,521.21
Jan. 27, 2025CMO52,592$285.00Sell$14,988,720.00
Jan. 23, 2025Director11,250$275.00Sell$3,093,750.00
Dec. 12, 2024CMO1,752$251.00Sell$439,752.00
Nov. 26, 2024EVP1,469$250.98Sell$368,689.62
Nov. 26, 2024CEO5,219$250.98Sell$1,309,864.62
Nov. 26, 2024CMO1,682$250.98Sell$422,148.36
Aug. 20, 2024CEO15,000$280.00Sell$4,200,000.00
Aug. 6, 2024Director20,250$262.00Sell$5,305,500.00
Aug. 1, 2024CEO15,148$270.00Sell$4,089,960.00
July 11, 2024CEO7,093$261.00Sell$1,851,273.00
June 25, 2024CEO8,301$230.99Sell$1,917,447.99
June 25, 2024CMO2,103$230.99Sell$485,771.97
June 25, 2024EVP1,198$230.99Sell$276,726.02
June 25, 2024CFO1,605$231.00Sell$370,755.00
June 24, 2024Director32,450$220.69Sell$7,161,390.50
May 29, 2024Director21,700$148.60Sell$3,224,620.00
Dec. 27, 2023Director30,000$195.00Sell$5,850,000.00
Aug. 7, 2023CMO4,166$183.89Sell$766,085.74
Aug. 4, 2023CEO4,057$185.85Sell$753,993.45
Aug. 4, 2023CMO3,461$185.85Sell$643,226.85
First«1 of 4»Last
  • Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.

  • The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Pushkal Garg, Laurie Keating, Barry E Greene, Tolga Tanguler, Kevin Joseph Fitzgerald, Jeffrey V Poulton, Philip A Sharp, Michael Mason, Paul Schimmel, Dennis A Ausiello, Laurence Reid, Michael W Bonney, Sanofi, Steven M Paul, Kevin P Starr, Phillip A Sharp, Indrani Lall Franchini, David E I Pyott, Amy W Schulman, David-Alexandre C Gros, John Clarke, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, Phillip A. Sharp, and Colleen F Reitan

  • The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.

  • John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.

  • Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.

  • The most recent insider trade for Alnylam Pharmaceuticals Inc was on March 3, 2026.

  • The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.

  • The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Pushkal Garg with a total value of $14,988,720.00 on Jan. 27, 2025.